SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.

Saved in:
Bibliographic Details
Title: SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers.
Authors: Wang, Xiaoqing1 (AUTHOR), Zhang, Longshan1 (AUTHOR), Liao, Liwei1 (AUTHOR), Li, Nan1 (AUTHOR), Tang, Tingxi1 (AUTHOR), Sun, Jianda1,2 (AUTHOR), Zhou, Zhenhua3 (AUTHOR), Liu, Yang4 (AUTHOR), Huang, Jihong3 (AUTHOR), Wang, Yingqiao1 (AUTHOR), Chen, Zekai1 (AUTHOR), Zhang, Hanbin1 (AUTHOR), Xiao, Ting1 (AUTHOR), Tian, Yunming1 (AUTHOR), Zheng, Xiuting1 (AUTHOR), Yuan, Yi1 (AUTHOR), Xiao, Linlin1 (AUTHOR), Liu, Laiyu3 (AUTHOR) liulaiyu@sina.com, Guan, Jian1,5 (AUTHOR) guanjian5461@163.com
Source: Clinical & Translational Medicine. Mar2024, Vol. 14 Issue 3, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.1624